Strategies to Mitigate the Toxicity of Cancer Therapeutics

Contributors in this volume include:
Annemieke Kavelaars
Nitesh Kumar
Imad Damaj
Ningjun Li
Maryam Lustberg
Hamid Akbarali
Fadi Salloum

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Genética (não médica)
• Virologia (não médica)
• Imunologia
• Biologia Celular (citologia)

Anthracyclines; Antineoplastic agents; Cancer; Cancer therapy; Cardiotoxicity; Cardiovascular imaging; Chemotherapy; Cognitive dysfunction; Diarrhea; Drug toxicity; Enteric nervous system; Gastrointestinal epithelium; Gliogenesis; Heart failure; Immune checkpoint; Immune checkpoint inhibitors; Inflammation; Ion channel; Kidney toxicity; Long-term adverse events; Microbiome; Mucositis; Neuroinflammation; Non-coding RNAs; Oxidative stress; Radiation; Radiation therapy; Risk factor; Sphingolipids; Survivorship; Symptom assessment; Targeted cancer therapy; Targeted therapy; Toxicity; Tyrosine kinase inhibitors